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Abstract
Troponin, a known marker for cardiac damage, also plays a role in predicting mortality and morbidity in
patients with intracerebral hemorrhage (ICH). Elevated troponin levels have been noted in patients with
ICH and studies have shown that such patients are more likely to experience adverse outcomes. The
mechanism behind this is suggested to be the release of sympathetic hormones causing myocardial
injury. The first differential that often comes to mind when a physician sees an elevated troponin level is a
myocardial infarction (MI). In this paper, we present a case of a 54-year-old female who presented to the
ED with nausea, vomiting, and severe headache with a troponin level of 47,000. This patient was initially
treated with heparin for a non-ST elevation myocardial infarction (NSTEMI), but CT of the head showed
ICH. Since part of the treatment protocol for a MI is heparin drip, not recognizing ICH as an underlying
cause of MI could lead to worsened hemorrhage and death.
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CASE REPORT

Elevated Troponin in Patients With
Intracerebral Hemorrhage
Kaycee Umeoji a,*, Uma Yoganathan a, Ann A. Palathingal b,*
a
b

Arnot Ogden Medical Center (AOMC), USA
Lake Erie College of Osteopathic Medicine, USA

Abstract
Troponin, a known marker for cardiac damage, also plays a role in predicting mortality and morbidity in patients with
intracerebral hemorrhage (ICH). Elevated troponin levels have been noted in patients with ICH and studies have shown
that such patients are more likely to experience adverse outcomes. The mechanism behind this is suggested to be the
release of sympathetic hormones causing myocardial injury. The ﬁrst differential that often comes to mind when a
physician sees an elevated troponin level is a myocardial infarction (MI). In this paper, we present a case of a 54-year-old
female who presented to the ED with nausea, vomiting, and severe headache with a troponin level of 47,000. This patient
was initially treated with heparin for a non-ST elevation myocardial infarction (NSTEMI), but CT of the head showed
ICH. Since part of the treatment protocol for a MI is heparin drip, not recognizing ICH as an underlying cause of MI
could lead to worsened hemorrhage and death.
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1. Introduction

I

ntracerebral hemorrhage is the term for bleeding
in the brain parenchyma. With an in-hospital
mortality rate up to 50%, ICH is considered one of
the most dangerous types of strokes.1 Survivors of
stroke often experience disability, including motor
deﬁcits, one of the most common functional deﬁcits
noticed after stroke. The long-term home care and
rehabilitation often required for stroke survivors
also places a ﬁnancial burden on patients and
families.1
The usage of non-contrast CT to diagnose ICH is
well-known, but perhaps a lesser-known phenomenon is the association between ICH and elevated
troponin levels.2 The mechanism proposed to be
behind the elevation of troponin in ICH is sympathetic nervous system (SNS) activation leading to
the release of catecholamines that can cause
myocardial injury.2 There have been studies that

have shown that patients with ICH who have
elevated troponin levels are at higher risk for inhospital mortality.3 The neurocardiac mechanism
behind elevated troponin levels in ICH is also suspected to lead to ischemia, abnormalities in wall
motion, and systolic dysfunction of the left
ventricle.4 The norepinephrine released during
sympathetic activation is also surmised to damage
nerve terminals.4 Myocardial damage itself is also
associated with decreased cerebral perfusion, which
potentially explains why elevated troponin levels in
ICH can reﬂect higher risk of adverse events.4
Since elevated troponin is more commonly associated with cardiac damage rather than ICH, this
could lead to the deadly mistake of giving heparin to
a patient with hemorrhagic stroke. This case presents a 54-year-old female with elevated troponin
levels who was eventually found to have an ICH
after initially being treated with heparin for a
NSTEMI. This report is intended to make more
clinicians aware that elevated troponin levels
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combined with the appropriate clinical presentation
should prompt further workup for ICH and delay
the administration of heparin.

2. Case presentation
A 54-year-old female with a past medical history
signiﬁcant for coronary artery disease, chronic kidney disease, hyperlipidemia, hypertension, and
diabetes mellitus type 1 presented to the emergency
department (ED) due to nausea and vomiting. The
patient's symptoms started after having dinner. She
vomited 8 times from dinner the previous night up
until admission. The vomit was nonbilious and nonbloody. The patient also reported a headache that
started the night before admission with a 10/10 intensity and unlike any of the headaches she had in
the past. She denied dizziness and confusion. She
also denied having shortness of breath and diaphoresis but endorsed chest pain. She took nitroglycerin 3 times for the chest pain and had minimal
relief at ﬁrst but eventually the pain level decreased.
She said that the chest pain was intermittent and
mild at admission and that she is comfortable
despite it. She denied recent travel or sick contacts.
Her past surgical history was signiﬁcant for triple
bypass and abdominal aortic aneurysm repair. Her
home medications included hydralazine, metoprolol, low dose Aspirin, and nitroglycerin (as needed).
Her family history and social history were noncontributory. She denied tobacco and illicit drug usage
but reported occasional alcohol usage. Her vitals
showed temperature of 98.2 F, heart rate of 86 beats
per minute, a blood pressure of 208/117 mmHg,
respirations of 18 breathes per minute, and O2
saturation of 98% on room air. Her physical examination showed a middle-aged female uncomfortable due to severe right temporal headache. Her
lungs were clear to auscultation but there were
decreased breath sounds at the lower bases bilaterally. The remainder of the physical examination
was within normal limits. The labs done in the ED
found a troponin level (high sensitivity) of
47,000 pg/mL. Her electrocardiogram showed ST
and T wave changes in leads I and aVL (Fig. 1). Her
chest x-ray did not show signs of congestive heart
failure (CHF). The CT of the abdomen and pelvis

did not show any abnormal ﬁndings. The patient
was initially thought to have only an NSTEMI.
Cardiology was consulted and the patient was
placed on the telemetry-monitored ﬂoor. The patient was placed on aspirin, labetalol, atorvastatin,
and heparin drip. She was also given a loading
bolus of heparin drip. Labetalol, morphine, and
intravenous (IV) hydralazine were given for blood
pressure control. After these orders were placed,
non-contrast head CT was performed about an hour
after admission since the patient reported having a
severe headache that did not improve (Fig. 2). The
CT showed right temporal lobe hemorrhage
spreading into the ventricles. Neurosurgery was
consulted and determined that the patient did not
need surgical intervention since she was clinically
stable and could be medically managed. Heparin
and aspirin were held given the risk of worsening
hemorrhage. Protamine was given to reverse the
heparin. Beta blocker and statin were continued.
Though the patient was initially admitted and
treated for NSTEMI only, ICH was added to diagnosis and surmised to be the main cause of the
elevated troponin level. The repeat CT showed no
signiﬁcant changes. Troponin trended downwards.
Her blood pressure also became more stable. The
patient was eventually discharged on Atorvastatin,

Fig. 2. Head CT showed right temporal lobe hemorrhage spreading into
ventricles.

Fig. 1. Electrocardiogram showed ST and T wave changes and QS complexes in leads I and aVL.
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Carvedilol, Hydralazine, Isosorbide mononitrate,
and Nitroglycerin (prn).

3. Discussion
A study done using data from a tertiary medical
center in 2013e2015 showed that among 306 patients with ICH, 27% had elevated troponin. The
mortality rate in the ICH group was 31.3%.5 This
stresses the importance of remembering that
although elevated troponin is widely associated with
MI, it can also signify MI secondary to ICH within
the proper context. In the case of this patient, she
reported both chest pain and headache. The headache was described as severe and unlike any
headache she has experienced in the past, warranting a head CT. The American College of Radiology deems that it is usually appropriate to order a
head CT without IV contrast if a patient has sudden,
severe headache.6
When a clinician sees elevated troponin levels,
there is often a strong tendency to think mainly
from a cardiac perspective. Troponin levels are
more often associated with cardiac myocyte damage
from myocardial infarction (MI). Although MI
should be on one's differential, it is important to
consider ICH as well depending on the patient
presentation. This patient's type of presentation is
the scenario where ICH should be on the differential. As previously mentioned, in this case, the patient reported a severe headache, prompting the
clinician to order a CT.
Heparin and aspirin can both be part of the
treatment protocol for NSTEMI. In this case, both
these medications were initially used in this patient
prior to CT results being available. The elevated
troponin prompted the clinician to treat her for
NSTEMI without considering the repercussions of
treating a patient who may have ICH with heparin.
As mentioned, she did end up having ICH and the
loading bolus of heparin already given may have
worsened the hemorrhage in terms of size.
Furthermore, heparin is also used in hospitalized
patients for thromboembolism prophylaxis. Such
usage of anticoagulants and antiplatelet therapy can
be deadly in ICH as it can worsen the hemorrhage.
It is important to discontinue aspirin and/or heparin
if these were started prior to establishing diagnosis
of ICH and refrain from using these if ICH is diagnosed beforehand. This leads us to the question
when is it acceptable to use anticoagulants and antiplatelet therapy in patients with elevated troponin?
The answer is that it depends on the clinical presentation of the patient. NSTEMI and ICH present
very differently when viewed individually. The
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former often presents with chest pain, while the
latter presents with headache. In this case, NSTEMI
and ICH presented together, and it may have been
appropriate to hold off on anticoagulant/antiplatelet
therapy until a head CT result is obtained. On the
contrary, if a patient presented with no headache
and purely symptoms of NSTEMI, such as chest
pain and diaphoresis, then anticoagulant/antiplatelet therapy should be given.

4. Conclusion
The recognition that elevated troponin levels
can be a result of ICH can help clinicians maintain
a high degree of suspicion for ICH. ICH can be
missed if a clinician thinks solely from a cardiac
standpoint when troponin levels are elevated, and
the electrocardiogram shows ischemic changes.
Treating a patient with ICH using MI treatment
protocol can have dire consequences. To prevent
this deadly circumstance, clinicians should be
educated more on elevated troponin and ICH and
encouraged to keep ICH on their differential
when appropriate. Bringing awareness to the
predictive value of elevated troponin levels in
patients with ICH can assist physicians with
clinical decision-making and potentially improve
patient outcomes.
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